Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near

ARKO Corp. (ARKO) is Attracting Investor Attention: Here is What You Should Know
ARKO Corp. (ARKO) is Attracting Investor Attention: Here is What You Should Know

ARKO Corp. (ARKO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the

Zacks.com featured highlights Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont
Zacks.com featured highlights Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont

For Immediate Release

Chicago, IL – May 2, 2025 – The stocks in this week’s article are Fox FOXA, Universal Technical Institute UTI, Pfizer PFE, Tenet Healthcare THC and Newmont NEM.

Looking for

Twilio Stock Soars 9% on Q1 Earnings Beat & FY25 Guidance Raise
Twilio Stock Soars 9% on Q1 Earnings Beat & FY25 Guidance Raise

Twilio Inc. TWLO shares jumped 9.1% in the extended trading session on Thursday after the company reported better-than-expected first-quarter results and raised guidance for full-year 2025.

The

5 Fidelity Mutual Funds to Buy Amid Market Uncertainty
5 Fidelity Mutual Funds to Buy Amid Market Uncertainty

The U.S. market remains volatile due to shifting foreign policies and rising geopolitical tensions. Investors are still concerned about the impact of new reciprocal tariff policies on domestic

Zacks.com featured highlights Griffon, Nomad Foods, DXP Enterprises and Limbach
Zacks.com featured highlights Griffon, Nomad Foods, DXP Enterprises and Limbach

For Immediate Release

Chicago, IL – May 2, 2025 – The stocks in this week’s article are Griffon Corp. GFF, Nomad Foods Ltd. NOMD, DXP Enterprises, Inc. DXPE and Limbach Holdings, Inc. LMB.

Scoop Up

How to Boost Your Portfolio with Top Consumer Discretionary Stocks Set to Beat Earnings
How to Boost Your Portfolio with Top Consumer Discretionary Stocks Set to Beat Earnings

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

Why Investors Need to Take Advantage of These 2 Consumer Discretionary Stocks Now
Why Investors Need to Take Advantage of These 2 Consumer Discretionary Stocks Now

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

The

How to Boost Your Portfolio with Top Computer and Technology Stocks Set to Beat Earnings
How to Boost Your Portfolio with Top Computer and Technology Stocks Set to Beat Earnings

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

Despite Fast-paced Momentum, Tenet (THC) Is Still a Bargain Stock
Despite Fast-paced Momentum, Tenet (THC) Is Still a Bargain Stock

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks

Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now
Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the

Recent Price Trend in Golar LNG (GLNG) is Your Friend, Here's Why
Recent Price Trend in Golar LNG (GLNG) is Your Friend, Here's Why

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a

Fast-paced Momentum Stock LATAM (LTM) Is Still Trading at a Bargain
Fast-paced Momentum Stock LATAM (LTM) Is Still Trading at a Bargain

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that

Viavi Beats Q3 Earnings Estimates on Healthy Revenue Growth
Viavi Beats Q3 Earnings Estimates on Healthy Revenue Growth

Viavi Solutions Inc. VIAV reported solid third-quarter fiscal 2025 results, with both the top and bottom lines surpassing the Zacks Consensus Estimate. The company reported an increase in revenues

GM Trims Outlook, Halts Buyback Amid Tariffs: Sell the Stock Now?
GM Trims Outlook, Halts Buyback Amid Tariffs: Sell the Stock Now?

General Motors GM has lowered its 2025 earnings forecast, warning that new U.S. auto tariffs could cost the company $4-$5 billion. The updated guidance, released yesterday, comes two days after the

Interactive Brokers Reports Y/Y Increase in April Client DARTs
Interactive Brokers Reports Y/Y Increase in April Client DARTs

Interactive Brokers Group, Inc. IBKR has released the Electronic Brokerage segment’s performance metrics for April 2025. The segment deals with the clearance and settlement of trades for individual

Ingersoll Rand's Q1 Earnings and Revenues Miss Estimates
Ingersoll Rand's Q1 Earnings and Revenues Miss Estimates

Ingersoll Rand Inc. IR reported first-quarter 2025 adjusted earnings of 72 cents per share, which missed the Zacks Consensus Estimate of 73 cents. The bottom line decreased 7.7% year over year.Total

FuboTV Inc. (FUBO) Reports Q1 Loss, Tops Revenue Estimates
FuboTV Inc. (FUBO) Reports Q1 Loss, Tops Revenue Estimates

FuboTV Inc. (FUBO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.11 per share a year ago. These figures are

Will Solid Segmental Sales Boost TransDigm's Q2 Earnings?
Will Solid Segmental Sales Boost TransDigm's Q2 Earnings?

TransDigm Group Incorporated TDG is slated to report second-quarter fiscal 2025 results on May 6, before market open.TransDigm delivered a trailing four-quarter average earnings surprise of 6.50%

DuPont's Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
DuPont's Q1 Earnings Surpass Estimates, Revenues Increase Y/Y

DuPont de Nemours, Inc. DD registered a loss from continuing operations of $548 million or $1.33 per share for first-quarter 2025. In the year-ago quarter, the company recorded a profit of $183

Telephone & Data Systems (TDS) Reports Q1 Loss, Misses Revenue Estimates
Telephone & Data Systems (TDS) Reports Q1 Loss, Misses Revenue Estimates

Telephone & Data Systems (TDS) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.10 per share a year ago

United States Cellular (USM) Q1 Earnings and Revenues Miss Estimates
United States Cellular (USM) Q1 Earnings and Revenues Miss Estimates

United States Cellular (USM) came out with quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.20 per share a year ago

Madison Square Garden (MSGS) Reports Q3 Loss, Misses Revenue Estimates
Madison Square Garden (MSGS) Reports Q3 Loss, Misses Revenue Estimates

Madison Square Garden (MSGS) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of $1.48. This compares to earnings of $1.57 per share a year ago. These figures

CBOE Global (CBOE) Q1 Earnings and Revenues Beat Estimates
CBOE Global (CBOE) Q1 Earnings and Revenues Beat Estimates

CBOE Global (CBOE) came out with quarterly earnings of $2.50 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $2.15 per share a year ago. These

Implied Volatility Surging for Keros Therapeutics Stock Options
Implied Volatility Surging for Keros Therapeutics Stock Options

Investors in Keros Therapeutics, Inc. KROS need to pay close attention to the stock based on moves in the options market lately. That is because the May 16, 2025 $70.00 Call had some of the highest